Plasma endothelin-1 activity is significantly elevated in black African women with pre-eclampsia and correlates with lower birth weight.
This is the authors' abstract. We don't add key points for this paper.
Plasma endothelin-1 activity was measured by radioimmunoassay in 24 normotensive non-pregnant women and in 24 normotensive pregnant, 24-aproteinuric hypertensive and 24 pre-eclamptic women. Endothelin-1 activity was increased in the pre-eclamptic group (2.7 +/- 06 pg/ml) compared to the normotensive non-pregnant (1.0 +/- 0.8 pg/ml; P < 0.0001), normotensive pregnant (1.2 +/- 0.4 pg/ml; P < 0.0001) group and the aproteinuric hypertensive group (1.4 +/- 0.7 pg/ml; P < 0.0001). There was no difference in endothelin-1 activity between the normotensive non-pregnant and normotensive pregnant group (1.0 +/- 0.8 vs. 1.2 +/- 0.4 pg/ml; P = 0.3). However, there was a difference between the aproteinuric hypertensive group (1.4 +/- 0.7 pg/ml) and both the normotensive nonpregnant (1.0 +/- 0.8 pg/ml; P < 0.01) and the normotensive pregnant group (1.2 +/- 0.4 pg/ml; P < 0.06). The birth weight in the pre-eclamptic group (2.48 +/- 0.61 kg) was significantly lower than that of the normotensive pregnant group (2.85 +/- 0.33 kg; P < 0.001) and the aproteinuric hypertensive group (2.99 +/- 0.46 kg; P < 0.001). In addition, there was no difference in birth weight between the normotensive pregnant group and aproteinuric hypertensive group (2.85 +/- 0.33 vs. 2.99 +/- 0.46 kg; P = 0.3). A significant Pearson's correlation of plasma endothelin-l versus birth weight in the pre-eclamptic group was obtained (r = 0.64; P < 0.0001). Endothelin-1 activity is increased with pre-eclampsia in black African women with pre-eclampsia. The results of our study also suggests an ethnic difference in plasma endothelin-1 activity when compared to result of studies carried out in Caucasian women with hypertensive disorders of pregnancy.
Answers are grounded in this paper and cite their sources.
Elevated endothelin-1 in pre-eclampsia is hypothesis-generating; leaves open its prognostic or therapeutic value in this population.
No takes yet. Share an insight, caveat, or question.
Khedun et al. (2002) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: